创新药概念板块走强 恒瑞医药(01276)涨超11% 券商看好ADC、双抗等出海赛道

金吾财讯
Oct 28

金吾财讯 | 创新药概念板块走强,截至发稿,恒瑞医药(01276)涨11.14%,金斯瑞生物(01548)涨9.39%,康方生物(09926)涨4.70%,诺诚健华(09969)涨3.50%,欧康维视生物-B(01477)涨3.33%,亚盛医药(06855)涨2.65%,翰森制药(03692)涨2.32%。消息面上,招商证券指出,2026年ESMO年会中国研究入选LBA约30项数量创新高,创新药数据催化临近;同时三季报进入披露期,业绩兑现方向值得重视,继续看好创新药产业趋势。爱建证券指出,医药板块已步入长期布局的价值区间,众多上市公司推出现金回购和增持方案,反映出企业家和高管团队对于公司未来发展的充足信心,也是板块企稳的积极信号。2026年,继续看好中国创新药出海的产业趋势,继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10